![Peter Collins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 144 900 $ as of 2026-05-30
Peter Michael Collins is the founder of European Personalised Medicine Association.
Mr. Collins is Chief Executive Officer & Director at CelLBxHealth Plc since 2026.
Mr. Collins was Chief Executive Officer at SAGA Diagnostics AB. Mr. Collins was Director & Chief Commercial Officer at Yourgene Health Ltd. Mr. Collins was Vice President & Head-Diagnostics at GSK Plc.
Mr. Collins was Principal at Riverside Biosciences Ltd., BioGenex Laboratories, Inc., Gentronix Ltd., and Pronostics Ltd. Mr. Collins was Senior Vice President-Pharma Business Development at DxS Ltd. Mr. Collins was Vice President-Marketing & Sales at Abbott Molecular Diagnostics.
Mr. Collins was Vice President-Pharma Business Development at QIAGEN Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELLBXHEALTH PLC 0.44% | 2025-12-17 | 5,000,000 ( 0.44% ) | 144 900 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CELLBXHEALTH PLC | Chief Executive Officer | 2025-10-15 |
| Companies | Position | End |
|---|---|---|
| YOURGENE HEALTH | Director/Board Member | 2018-10-31 |
SAGA Diagnostics AB
 SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Chief Executive Officer | - |
| GSK PLC | Corporate Officer/Principal | - |
Qiagen Ltd.
 Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities | Corporate Officer/Principal | - |
European Personalised Medicine Association | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 12 |
|---|---|
CelLBxHealth Plc
 CelLBxHealth Plc Medical DistributorsDistribution Services Operates as a holding company with interests in providing products in cancer diagnostics and foetal health | Distribution Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Riverside Biosciences Ltd.
 Riverside Biosciences Ltd. Medical SpecialtiesHealth Technology Produces neo natal blood testing kits | Health Technology |
BioGenex Laboratories, Inc.
 BioGenex Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Provides solutions for automation of cell and tissue testing | Health Technology |
Gentronix Ltd.
 Gentronix Ltd. BiotechnologyHealth Technology Provides services and solutions to help organizations optimize the development of drugs and other chemicals | Health Technology |
Pronostics Ltd.
 Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Provides and develops diagnostic test for heart disease | Health Technology |
DxS Ltd.
 DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Health Technology |
Abbott Molecular Diagnostics | |
Qiagen Ltd.
Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities | Health Services |
European Personalised Medicine Association | |
Yourgene Health Plc
 Yourgene Health Plc Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
